LogicBio Therapeutics (LOGC) Misses Q1 EPS by 27c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +82.6%
Financial Fact:
Sales, general and administrative: 167.9K
Today's EPS Names:
HFBL, PBHC, PBNK, More
EPS Growth %: +82.6%
Financial Fact:
Sales, general and administrative: 167.9K
Today's EPS Names:
HFBL, PBHC, PBNK, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q1 EPS of ($0.27).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regency Centers (REG) Tops Q2 EPS by 2c
- Kotak Downgrades Dixon Technologies India Ltd (DIXON:IN) to Add (2)
- ITC Ltd. (ITC:IN) PT Lowered to INR310 at JPMorgan
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
